Cipher Pharma (TSX:CPH) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 21.05 percent. This is a 31.82 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $12.067 million which missed the analyst consensus estimate of $13.606 million by 11.31 percent. This is a 9.82 percent decrease over sales of $13.381 million the same period last year.